PLATELET DESTRUCTION INCREASED

PLATELET DESTRUCTION INCREASED was reported 45 times

PLATELET DESTRUCTION INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thrombopoietin Receptor Agonist [EPC] 5 0.0003
1 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 1 0.0001
2 Antifibrinolytic Agent [EPC] 1 0.0001
3 Human Immunoglobulin G [EPC] 1 0.0000
4 Insulin [EPC] 2 0.0000
5 Iron Chelator [EPC] 1 0.0000
6 BCL-2 Inhibitor [EPC] 2 0.0000
7 Purine Antimetabolite [EPC] 3 0.0000
8 Soluble Guanylate Cyclase Stimulator [EPC] 1 0.0000
9 Tetracycline-class Drug [EPC] 2 0.0000
10 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
11 CD20-directed Cytolytic Antibody [EPC] 7 0.0000
12 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
13 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0000
14 Alkylating Drug [EPC] 4 0.0000
15 Glycopeptide Antibacterial [EPC] 1 0.0000
16 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
17 Loop Diuretic [EPC] 4 0.0000
18 Proteasome Inhibitor [EPC] 1 0.0000
19 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
20 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
21 Prostacycline Vasodilator [EPC] 1 0.0000
22 Leukocyte Growth Factor [EPC] 1 0.0000
23 Platelet Aggregation Inhibitor [EPC] 4 0.0000
24 Osmotic Laxative [EPC] 2 0.0000
25 Calcium [EPC] 1 0.0000
26 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
27 Proton Pump Inhibitor [EPC] 3 0.0000
28 Endothelin Receptor Antagonist [EPC] 1 0.0000
29 RANK Ligand Inhibitor [EPC] 1 0.0000
30 Expectorant [EPC] 1 0.0000
31 Corticosteroid [EPC] 6 0.0000
32 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
33 Anti-epileptic Agent [EPC] 1 0.0000
34 Opioid Agonist [EPC] 1 0.0000
35 Kinase Inhibitor [EPC] 2 0.0000
36 beta-Adrenergic Blocker [EPC] 1 0.0000
37 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
38 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
39 Vitamin C [EPC] 1 0.0000
40 Insulin Analog [EPC] 1 0.0000
41 Tumor Necrosis Factor Blocker [EPC] 1 0.0000